(Q44733247)

5 December 2017

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy (English)

1 reference

5 December 2017

information technology

1 reference

1

1 reference

5 December 2017

T Bek

10

0 references

author name string

O Thornórisdóttir

2

1 reference

5 December 2017

E Olafsdottir

3

1 reference

5 December 2017

A Gudmundsdottir

4

1 reference

5 December 2017

A B Einarsdóttir

5

1 reference

5 December 2017

J Mehlsen

6

1 reference

5 December 2017

S Einarsson

7

1 reference

5 December 2017

O Pálsson

8

1 reference

5 December 2017

G Einarsson

9

1 reference

5 December 2017

E Stefánsson

11

1 reference

5 December 2017

27 July 2011

1 reference

5 December 2017

1 reference

5 December 2017

54

1 reference

5 December 2017

10

1 reference

5 December 2017

2525-2532

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-011-2257-7

5 December 2017

0 references

cites work

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Screening and prevention of diabetic blindness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

New blindness in diabetes reduced by more than one-third in Stockholm County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

The English national screening programme for sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Active prevention in diabetic eye disease. A 4-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Screening for eye disease in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Systematic screening for diabetic eye disease in insulin dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Screening compliance and visual outcome in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2257-7

Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis

21 January 2018

1 reference

12 December 2020

Individualized optimization of the screening interval for diabetic retinopathy: a new model

1 reference

12 December 2020

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance

1 reference

12 December 2020

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

1 reference

12 December 2020

Screening for diabetic retinopathy. Initiation and frequency

1 reference

12 December 2020

Validation, calibration, revision and combination of prognostic survival models

1 reference

12 December 2020

Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme

1 reference

12 December 2020

Cost-effectiveness of strategies for detecting diabetic retinopathy.

1 reference

12 December 2020

10.1007/S00125-011-2257-7

Identifiers

DOI

1 reference

5 December 2017

1 reference